Skip to main content
SIU School of Medicine Logo

Domain Menu

  • Patient Care
  • School of Medicine

Main Menu Edu Secondary

  • faculty
  • intranet
  • library
  • news & events
  • donate
  • careers
I am a...
  • Patient
  • Donor or Friend
  • Prospective Employee
  • Student/Prospective Student
  • Resident or Fellow
  • Alumni

Main Menu Edu

Main Menu Close
Main Menu
  • Degree Programs
  • Research
  • Academic & Clinical Departments
  • Centers & Institutes
  • Community Programs
    • External Relations
    • Family and Community Medicine
    • Office of Community Care
    • Population Science and Policy
    • Rural Health and Social Service Development
  • About Us
    • Administrative offices
    • Careers
    • Why SIU School of Medicine
      • Strategic plan
      • A Model for Medical Education
      • Facts and figures
      • Our campuses
    • History
      • Notable alumni
      • Points of pride
      • Timeline
    • Leadership
      • SIU Medicine Board of Directors
      • SIU School of Medicine Leadership
    • News and Events
Search Site close Close

Breadcrumb

  1. Home
  2. Trials and Research Search
clinical trials

Clinical trials and research studies

At SIU Medicine, our researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.
search
Reset

Filter Results

Activity Status

  • (-) Active, recruiting (15)
  • Active, not recruiting (7)
  • Inactive, not recruiting (1)

Treatment

  • Abdominal Aortic Aneurysm (1)
  • Alzheimer's Disease (2)
  • Congestive Heart Failure (1)
  • Dementia (1)
  • Diabetes (1)
  • High Blood Pressure (Hypertension) (2)
  • Male Infertility and Sexual Dysfunction (1)
  • Muscular Dystrophy (1)
  • Parkinson's Disease (2)
  • Psoriasis (1)
  • Transcranial Magnetic Stimulation (TMS) (1)

Department

  • Alzheimer's Center (1)
  • Cardiothoracic Surgery (1)
  • Internal Medicine (1)
  • Neurology (3)
  • Neuroscience Institute (1)
  • Neurosurgery (1)
  • Psychiatry (1)
  • Pulmonary and Critical Care (1)
Reset

Filter Results

Activity Status

  • (-) Active, recruiting (15)
  • Active, not recruiting (7)
  • Inactive, not recruiting (1)

Treatment

  • Abdominal Aortic Aneurysm (1)
  • Alzheimer's Disease (2)
  • Congestive Heart Failure (1)
  • Dementia (1)
  • Diabetes (1)
  • High Blood Pressure (Hypertension) (2)
  • Male Infertility and Sexual Dysfunction (1)
  • Muscular Dystrophy (1)
  • Parkinson's Disease (2)
  • Psoriasis (1)
  • Transcranial Magnetic Stimulation (TMS) (1)

Department

  • Alzheimer's Center (1)
  • Cardiothoracic Surgery (1)
  • Internal Medicine (1)
  • Neurology (3)
  • Neuroscience Institute (1)
  • Neurosurgery (1)
  • Psychiatry (1)
  • Pulmonary and Critical Care (1)
Showing: 15 Results
search
Trial
Pulmonary and Critical Care

A randomized, double-blind, placebo-controlled dose escalation and verification clinical study to assess the safety and efficacy of pulsed, inhaled nitric oxide in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy

Active recruiting
The purpose of this study is to determine if the study drug, inhaled nitric oxide (iNO), when given and breathed through an investigational study device, the INOpulse, may help treat patients at risk for pulmonary hypertension-pulmonary fibrosis. Another purpose of this study is to determine if using the INOpulse delivery device (drug and device combination) improves the levels of moderate to vigorous physical activity (for example walking, climbing stairs, household chores and cleaning and, exercise and hobbies), as measured by actigraphy (a non-invasive way to monitor rest/activity).
Contact: Rebecca Coughlin phone217-545-7321 emailrcoughlin59@siumed.edu
Trial
Vascular Surgery

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms: AAA 13-03

Active recruiting

The purpose of this study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis (Study Device) when used for the treatment of Abdominal Aortic Aneurysms (AAA).

Contact: Kristal Adams phone217-545-7812 emailkadams@siumed.edu
Trial
Neurology

Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

Active recruiting

ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.

Contact: Sara Boarman phone217-545-6829 emailsboarman93@siumed.edu
Trial
Neurology

Caregiver Characteristics That May Predict When Patients With Alzheimer Disease Are Placed in Long Term Care Facilities

Active recruiting
This research will be conducted by the SIU Memory and Aging Network (MAN), which comprises 38 sites that evaluate and treat patients with dementia throughout non-metropolitan Illinois.  AD patients and their caregivers who are living in private homes will be recruited.  Primary outcome measures will be the ratings of the caregiver’s physical status (grip strength, walking speed, and score on the Timed Up-and-Go Test11 and the rating of the caregiver’s chronic medical illness burden using the Cumulative Illness Rating Scale (Geriatric).12,13  The patient and caregiver dyad is required.
Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
Trial
Cardiothoracic Surgery

Clinical Study of the BioVentrix TC System for the Treatment of Left Ventricular Aneurysm

Active recruiting

The purpose of the study is to demonstrate the safety and effectiveness of the BioVentrix Revivent TC System for the treatment of LV antero-septal aneurysms/scars in patients with symptomatic heart failure.

Contact: Katie Mottershaw phone217-545-7387 emailkmottershaw33@siumed.edu
Trial
Dermatology

Corrona Psoriasis (PSO) Registry

Active recruiting

The objective of the Corrona Psoriasis Registry is to create a national database of patients with psoriasis. Data collected will be used to study the  disease and to evaluate the effectiveness and safety of medications approved for the treatment of psoriasis.

Contact: Rebecca Coughlin phone217-545-7321 emailrcoughlin59@siumed.edu
Trial
Endocrinology

Family healthcare advocate Integrated with medical Specialists to improve cardiometabolic Health (FISH)

Active recruiting

The purpose of this study is to evaluate the impact of a Family Healthcare Advocate in management of Type 2 Diabetes and Hypertension among SIU Medicine Endocrinology patients residing in Springfield, IL zip codes 62702 and 62703.

Contact: Rebecca Coughlin phone217-545-7321 emailrcoughlin59@siumed.edu
Trial
Neurology

MDA: Neuromuscular Observational Research

Active recruiting

MOVR:  Data Hub is the first and only data hub that aggregates clinical, genetic, and patient reported data for multiple nuromuscular diseases.  Collection of patient data about disease progression in the era of new treatments will inform and accelerate future innovation.  The combination of data collected through MOVR Data Hub will provide a comprehensive understanding of health and patient experiences in a single data repository.  MOVR Data Hub has the power to transform health outcomes, accelerate drug development and drive clinical research across multiple neuromuscular diseases, helpin

Contact: Stephanie Kohlrus phone217-545-3013 emailskohlrus@siumed.edu
Trial
Neurology

NX Corp.: A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas

Active recruiting

NXDC-MEN-301: Subjects are being asked to participate in this study because they have a brain tumor, a meningioma, and surgery is recommended to remove it.  The sponsor of this clinical trial, NX Development Corp, has developed the study drug, Gleolan, an imaging agent that in some brain tumors, can make the tumors glow red-violet under a special blue light. This may make it easier for the study surgeon to identify the tumor and to remove it.  As part of the study, subjects will drink the Gleolan before your surgery.  The goal is to safely remove the tumor.

Contact: Barbara Lokaitis phone217-545-9737 emailblokaitis@siumed.edu
Trial
Neurology

Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment of Dyskinesia in Patients with Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications

Active recruiting

The purpose of this study is to evaluate the effectiveness, safety, and tolerability of the investigational drug, dipraglurant (ADX48621), in subjects with Parkinson’s disease (PD) and levodopa-induced dyskinesia (LID).

Contact: Sara Boarman phone217-545-6829 emailSara Boarman
Go back to search filters

Pagination

  • Current page 1
  • Page 2
  • Next page ››

This browser is no longer supported and some key features will not work. We strongly recommend using Edge, Chrome 70+, Safari 5.x+ and Firefox 5.x+.

SIU School of Medicine Logo
© 2022 SIU Board of Trustees all rights reserved

Legal

  • Equal Opportunity Employer
  • Nondiscrimination Statement
  • Privacy Policy
  • FOIA

About Us

  • About Us
  • Directory
  • Contact
  • My SIU
  • SIU Medicine
  • Southern Illinois University Carbondale
  • Southern Illinois University Edwardsville
  • Southern Illinois University System

Social

  • Facebook
  • Twitter
  • Youtube
  • Instagram